My Role in This Story
I'm an office administrator for a 130-person electronics company. I manage component purchasing across 8 vendors—roughly $400,000 annually. I report to both operations and finance, which means I get pressure from both sides: engineers want quality, finance wants lower costs.
When we started two product lines in 2023—a 5G smartphone we call the G310 5G and a home blood pressure monitor—I became the person tasked with finding the right components. This article is about what comparing Kemet relays and capacitors against generic alternatives taught me.
The Comparison Framework
We evaluated Kemet and generic suppliers across three dimensions:
- Total cost of ownership—not just unit price
- Reliability and traceability—what can be proven
- Supply chain certainty—what we can count on
The G310 5G phone and the blood pressure monitor have very different needs. A phone can tolerate some failure in non-critical circuits. A blood pressure monitor is different. When someone is learning how to use a blood pressure monitor at home, the reading needs to be right. Wrong values create panic or false reassurance. Both are bad outcomes.
Dimension 1: Total Cost vs. Unit Price
I'll be honest: the generic capacitors we evaluated were 30–40% cheaper than the Kemet equivalents. On paper, they looked like obvious wins. But total cost told another story.
The generic relays we ordered for the G310 5G had a 1.8% incoming failure rate. That meant rejected batches, extra testing hours, and rework on the production line. Our line runs about $42 per minute in labor and overhead. Even a small failure percentage translates into real money.
From the outside, it looks like a cheaper quote means the supplier is efficient. The reality is that the lowest quote is often just the beginning of the total cost picture. We also saw tolerance drift on the generic capacitors under temperature changes, which caused 6% of our assembled boards to fail final test during the phone's first production run.
For the blood pressure monitor, the calculation was even starker. The measurement circuit uses a pressure sensor with a capacitor in its signal path. When that capacitor's capacitance drifts with temperature—as the generic part did in our testing—the reading becomes inaccurate by several mmHg. For a consumer tracking hypertension, that inaccuracy isn't a minor inconvenience. It could affect a medication decision. That's why our engineers specified a ±5% tolerance capacitor from Kemet instead of the ±20% generic alternative.
A failed component in the field doesn't just mean a returned product. It means a medical device report, an investigation, and potentially a recall. The cost of a single field failure investigation would have wiped out every dollar saved from buying generic parts for an entire production run.
My rule since then: unit price is the tip of the iceberg. Total cost includes testing, rework, compliance, and risk.
Dimension 2: Reliability and Traceability
The blood pressure monitor needed components with full traceability. Lot numbers. Test data. Material certificates.
Kemet provided all of it, including documentation from their Kemet Simpsonville SC facility. Our quality engineer could trace every batch of capacitors to specific test date codes and lot numbers. That level of documentation matters when you need to answer questions from regulators.
The generic suppliers? One sent us three different spec sheets for the same product across three orders. Specifications kept changing. Another claimed "automotive grade" parts but couldn't produce the AEC-Q200 test data when we asked.
I asked our quality engineer why he was uncomfortable signing off on generic relays for the medical device. His answer stuck with me: "The part might be fine. But if I can't prove it's fine, we can't ship it in a medical device."
One thing that surprised me: the Kemet relays also performed better in thermal cycling tests. We ran 500 cycles between -40°C and 125°C. The contact resistance on the Kemet relays stayed within spec. The generic relays drifted more under the same test. I didn't appreciate how much that data mattered until we started looking at real-world reliability.
The G310 5G phone was more forgiving. We tested generic components in non-critical circuits like LED drivers and vibration feedback, and they passed. I suspect they'll work fine for years. The distinction wasn't "generic is bad." It was "generic needs proof, and proof costs time and money."
Dimension 3: Supply Chain Certainty
In 2021, a generic capacitor supplier extended lead times from 8 weeks to 24 weeks with no warning. Our existing inventory ran out in six weeks. The launch of a customer order nearly slipped. I had to call in favors and pay for expedited freight from another supplier just to keep the line running.
That was the moment I started valuing lead time certainty as much as unit price.
Kemet's Simpsonville SC facility has been responsive compared to offshore suppliers. When we had questions about a relay's switching characteristics, an engineer from the Simpsonville team replied within a day. With overseas suppliers, the answer often took a week and came through a sales agent with limited technical knowledge.
There's also the inventory cost angle. With predictable lead times from Kemet, we've reduced our safety stock on critical parts from eight weeks of coverage to three weeks. That's a real savings: carrying costs run about 20% of inventory value annually in our model.
The lesson here wasn't hard to learn. I knew I should have diversified suppliers earlier, but I thought "what are the odds?" Well, the odds caught up with me.
What I'd Recommend
If you're trying to decide between Kemet relays and generic alternatives, there's no single right answer. It depends on what you're building.
Choose Kemet for:
- Medical devices or products where failure creates safety or compliance risk
- Power management circuits in phones or industrial equipment
- Applications where traceable documentation matters
- Products that need predictable supply and consistent lead times
Consider generic components for:
- Prototypes and early development boards
- Non-critical circuits like status LEDs or basic filtering
- Products with high failure tolerance and low field risk
- When your incoming inspection can catch issues early
For the G310 5G, we ended up with a hybrid approach. Kemet capacitors for power management, generic for the less critical stuff. That split cut our BOM cost by about 12% while keeping failure rates at an acceptable level.
For the blood pressure monitor? Every critical component is Kemet. The 25% premium is a bargain compared to the cost of a field failure. I've approved that decision again and again since 2023, and it's held up.
Final Thoughts
I remember approving the first Kemet order and thinking, "Am I overpaying?" The answer turned out to be no. But it took eighteen months of data to confirm it.
One mistake helped crystallize my thinking. In 2024, we had a small recall scare on a connector used in a non-medical product. The connector was from a generic supplier, and we couldn't trace the defective batch to a specific manufacturing date or lot. We ended up replacing units for customers without knowing the actual scope of the problem. That lack of traceability cost us roughly $8,000 and a lot of scattered weekends.
So here's my practical advice: run your own total cost calculation. Use your own failure rates, labor costs, compliance burden, and customer expectations. The lowest upfront quote doesn't win most of the time. The supplier that protects your product's reputation wins. In our case, that has meant choosing Kemet for the components that matter most.
Pricing referenced here reflects our project experience in 2023–2024. Actual costs vary by configuration, volume, and market conditions—verify current pricing for your specific requirements.
